ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
VolitionRx Limited Announces Strategic Acquisition prnasia
December 17, 2019VolitionRx Limited (NYSE?AMERICAN: VNRX) ("Volition") today announced an agreement by its subsidiary Belgian Volition SPRL to acquire an epigenetic reagent company, Octamer GmbH ("Octamer"), for approximately $725,000 consisting of cash and shares of rest
Pharma Sources Insight January 2025
